Abstract Background There has been a significant improvement in survival of advanced malignancies with the advent of checkpoint inhibitors. These newer treatment modalities come with a wide spectrum of unique side effects. termed immune related adverse events (irAE). ranging from mild skin rash to severe colitis. https://www.ngetikin.com/